Related Articles
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: A phase II study with organ-sparing purposes
Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients
L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial
Double‑blind randomized study of oral glutamine on the management of radio/chemotherapy‑induced mucositis and dermatitis in head and neck cancer
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: A phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity